Mechanisms regulating tau alternative pre-mRNA splicing
Mechanisms regulating tau alternative pre-mRNA splicing
批准号:
8116362
负责人:
JANE Y WU
金额:
$31.26万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-15 至 2016-07-31
关键词:
AddressAffectAlternative SplicingBiochemicalBioinformaticsBiologicalBiological AssayCell Culture SystemCell DeathCellsComplexDNA SequenceDefectDementiaDiseaseDissectionElementsEnhancersExonsFrontotemporal DementiaGene MutationGenesGeneticGoalsHumanIn VitroLeadMass Spectrum AnalysisMethodsMolecularMolecular GeneticsMutationNerve DegenerationNeurodegenerative DisordersNeuronal DifferentiationNeuronsPathogenesisPatientsPatternPlayProteinsProteomicsPublishingRNA InterferenceRNA ProcessingRNA SplicingReagentRegulationRegulator GenesReportingResearchRisk FactorsRoleSamplingScreening procedureSpliced GenesStructureSurveysSystemTauopathiesTemporal LobeTestingTissue SampleTrans-ActivatorsTranscriptWorkbaseclinical phenotypecrosslinkexpression cloninggene functionmRNA Precursornervous system disorderneuron lossneuronal survivalstemtau Proteinstau expressiontau mutationtool
中文摘要
描述(申请人提供):调节tau蛋白替代前信使核糖核酸剪接的机制越来越多的证据表明,前信使核糖核酸剪接缺陷和异常剪接导致一系列神经退行性疾病。选择性剪接对tau基因的功能至关重要,而人类tau基因的剪接突变会导致额颞叶痴呆(FTLD-tau)。虽然tau剪接突变最早是在1998年被报道的,但突变影响tau选择性剪接的机制仍不清楚,FTLD-tau中的危险因素和遗传修饰物仍有待确定。本研究旨在探讨tau基因选择性剪接的调控机制。我们计划使用分子、生化和细胞生物学方法来研究tau的选择性剪接,并比较野生型和突变型tau转录本对剪接体的差异识别。我们已经建立了体外生化分析和细胞培养系统来研究tau外显子10的选择性剪接。在我们的初步研究中,我们利用生化分析和表达克隆策略,鉴定了与tau外显子10选择性剪接有关的几种蛋白质。还建立了一个原代神经元培养系统,以研究已确定的因素在神经细胞死亡中的作用。对tau选择性剪接重要的顺式和反式作用元件的分子解剖,不仅有助于了解控制tau选择性剪接的基本机制,而且还将揭示神经退行性变的新的发病机制。我们计划使用生物信息学、生化、分子和遗传学相结合的方法来研究FTLD-tau的发病机制,FTLD-tau是最常见的神经退行性疾病之一。
与公共卫生相关:压倒性证据支持异常的RNA处理在神经退行性变的发病机制中发挥重要作用,包括一种常见的神经疾病--脊椎病。影响tau前mRNA剪接的剪接突变导致tau病,然而,大多数tau病患者表现出tau前mRNA剪接调节障碍,而tau基因没有检测到突变。突变影响tau选择性剪接的机制还不是很清楚,而且tau病的危险因素和遗传修饰物仍有待确定。在已发表的工作和我们的初步研究的基础上,我们建议使用分子、生化和细胞生物学相结合的方法来研究突变如何影响tau的选择性剪接,并确定可能的危险因素或遗传修饰物,从而导致tau病的发生。
英文摘要
DESCRIPTION (provided by applicant): Mechanisms regulating tau alternative pre-mRNA splicing Accumulating evidence indicates that pre-mRNA splicing defects and aberrant splicing lead to a range of neurodegenerative disorders. Alternative splicing is critical for tau gene function, and splicing mutations in the human tau gene lead to fronto-temporal lobe dementia (FTLD-tau). Although tau splicing mutations were initially reported in 1998, the mechanisms by which mutations affect tau alternative splicing are still poorly understood, and risk factors as well as genetic modifiers in FTLD-tau remain to be identified. This proposal aims to investigate the mechanisms regulating tau gene alternative splicing. We plan to use molecular, biochemical and cell biological methods to investigate tau alternative splicing and to compare the differential spliceosomal recognition of wild type versus mutant tau transcripts. We have established both in vitro biochemical assays and cell culture systems to investigate tau exon 10 alternative splicing. Using biochemical assays and an expression cloning strategy, we have identified several proteins involved in tau exon 10 alternative splicing in our preliminary studies. A primary neuronal culture system has also been set up to investigate the role of identified factors in neuronal cell death. Molecular dissection of cis- and trans-acting elements important for tau alternative splicing will not only help in understanding the basic mechanisms controlling tau alternative splicing but also reveal new players in pathogenesis of neurodegeneration. We plan to use combined bioinformatics, biochemical, molecular and genetic approaches to study the pathogenetic mechanisms underlying FTLD-tau, one most common neurodegenerative disorders.
PUBLIC HEALTH RELEVANCE: Overwhelming evidence supports that aberrant RNA processing plays an important role in the pathogenesis of neurodegeneration, including tauopathy, a common neurological disease. Splicing mutations affecting tau pre-mRNA splicing lead to tauopathy, however, the majority of tauopathy patients show disturbance in tau pre-mRNA splicing regulation without detectable mutations in the tau gene. The mechanisms by which mutations affect tau alternative splicing are poorly understood, and risk factors as well as genetic modifiers in tauopathy remain to be identified. Based on published work and our preliminary studies, we propose to use a combined molecular, biochemical and cell biological approach to investigate how mutations affecting tau alternative splicing and to identify possible risk factors or genetic modifiers that contribute to pathogenesis of tauopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Mitochondria in TDP-43 Proteinopathy
-
批准号:10263156
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2018
-
负责人:JANE Y WU
-
依托单位:
The Role of Mitochondria in TDP-43 Proteinopathy
-
批准号:9788109
-
项目类别:
-
资助金额:$61.87万
-
财政年份:2018
-
负责人:JANE Y WU
-
依托单位:
The Role of Mitochondria in TDP-43 Proteinopathy
-
批准号:10458007
-
项目类别:
-
资助金额:$58.21万
-
财政年份:2018
-
负责人:JANE Y WU
-
依托单位:
The Role of Mitochondria in TDP-43 Proteinopathy
-
批准号:10012953
-
项目类别:
-
资助金额:$60.73万
-
财政年份:2018
-
负责人:JANE Y WU
-
依托单位:
The role of deubiquitinating enzyme USP33 in Slit-Robo signaling in lung cancer
-
批准号:8632559
-
项目类别:
-
资助金额:$45.67万
-
财政年份:2014
-
负责人:JANE Y WU
-
依托单位:
The role of deubiquitinating enzyme USP33 in Slit-Robo signaling in lung cancer
-
批准号:8819521
-
项目类别:
-
资助金额:$44.31万
-
财政年份:2014
-
负责人:JANE Y WU
-
依托单位:
The role of deubiquitinating enzyme USP33 in Slit-Robo signaling in lung cancer
-
批准号:9232089
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2014
-
负责人:JANE Y WU
-
依托单位:
Mechanisms regulating tau alternative pre-mRNA splicing
-
批准号:8311629
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2011
-
负责人:JANE Y WU
-
依托单位:
Mechanisms regulating tau alternative pre-mRNA splicing
-
批准号:8508774
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2011
-
负责人:JANE Y WU
-
依托单位:
Mechanisms regulating tau alternative pre-mRNA splicing
-
批准号:8726259
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2011
-
负责人:JANE Y WU
-
依托单位:
Searching for Genetic Modifiers of TDP-43 Proteinopathy Using an Animal Model
-
批准号:8270429
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2011
-
负责人:JANE Y WU
-
依托单位:
Slit Signaling in Breast Cancer
-
批准号:7414829
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2006
-
负责人:JANE Y WU
-
依托单位:
Slit Signaling in Breast Cancer
-
批准号:7239648
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2006
-
负责人:JANE Y WU
-
依托单位:
Slit Signaling in Breast Cancer
-
批准号:7091150
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2006
-
负责人:JANE Y WU
-
依托单位:
Slit Signaling in Breast Cancer
-
批准号:7615537
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2006
-
负责人:JANE Y WU
-
依托单位:
Slit Signaling in Breast Cancer
-
批准号:7798237
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2006
-
负责人:JANE Y WU
-
依托单位:
Alternative splicing regulation of caspase-2 gene
-
批准号:6867054
-
项目类别:
-
资助金额:$24.57万
-
财政年份:2005
-
负责人:JANE Y WU
-
依托单位:
Signal Transduction of the Netrin Pathway
-
批准号:7224870
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2005
-
负责人:JANE Y WU
-
依托单位:
Alternative splicing regulation of caspase-2 gene
-
批准号:7237808
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2005
-
负责人:JANE Y WU
-
依托单位:
Signal Transduction of the Netrin Pathway
-
批准号:7575830
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2005
-
负责人:JANE Y WU
-
依托单位:
海外基金